Lipid lowering agents to delay cognitive decline in Alzheimer's disease?
de Leeuw
F-E
FE
Department of Neurology (HP326), University Medical Centre St Radboud, PO Box 9101, 6500HB Nijmegen, Netherlands. h.deleeuw@neuro.umcn.nl.
D000544:Alzheimer Disease / Q000150:complications* / Q000503:physiopathology; D002784:Cholesterol; D003072:Cognition Disorders / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D000960:Hypolipidemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome
D000960:Hypolipidemic Agents; D002784:Cholesterol